Dr. Somnath Chatterjee has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
SURAKSHA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Dr. Somnath Chatterjee, on behalf of the promoters and promoter group entities (including persons acting in concert), has submitted a nil encumbrance declaration to the exchanges. The filing confirms that no new share encumbrances have been created in Suraksha Diagnostic Limited beyond what was already disclosed during the financial year ending 31 March 2026. The disclosure lists extensive promoter group members (3 main promoters with 56+ associated individuals) and 62 entities forming part of the promoter group, covering multiple companies, LLPs, and HUF entities. This is a routine compliance filing under SEBI regulations requiring promoters to periodically declare encumbrances on their shareholding.
This is a routine regulatory filing with no material new information. The confirmation of no additional encumbrances is a neutral-to-mildly positive signal, indicating no fresh pledge pressure on promoter shares. No immediate impact on the stock expected.